Delivery Order SPE2DE21D7020-SPE2D626F00FP
- Not listed
- Boston Scientific Corp has been awarded a $23,416 delivery order by the Defense Health Agency's Medical Supply Chain for WATCHMAN FLX PRO left atrial appendage closure devices. The award is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of December 16, 2025. The contract was issued without a small business set-aside, allowing unrestricted competition. Performance will take place at Boston Scientific's facility in Marlborough, Massachusetts,...
- Boston Scientific Corp has been awarded a delivery order valued at $19,576 for the provision of WATCHMAN FLX PRO left atrial appendage closure devices under a fixed-price contract with economic price adjustment provisions. The delivery order, issued on December 23, 2025, with completion scheduled for December 31, 2025, will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. This award was issued without a small business set-aside, allowing Boston...
- Boston Scientific Corp has been awarded a $45,058 delivery order by the Defense Health Agency's Medical Supply Chain for the WATCHMAN FLX PRO LAAC (Left Atrial Appendage Closure) Device. This fixed-price contract with economic price adjustment provisions is scheduled for completion by April 30, 2025, with performance taking place at Boston Scientific's Marlborough, Massachusetts facility. The contract was not set aside for any specific business type, reflecting open competition in the federal...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $19,576 for the supply of WATCHMAN FLX PRO left atrial appendage closure devices. The contract, issued on December 23, 2025, carries a fixed-price structure with economic price adjustment provisions and is set to conclude by December 31, 2025. The award was made by the Defense Health Agency's Medical Supply Chain division without a small business set-aside, allowing the established...
- Boston Scientific Corp was awarded a delivery order valued at $20,977 for the Watchman FLX Pro LAAC (left atrial appendage closure) device by the Defense Health Agency's Medical Supply Chain on June 4, 2025, with a completion deadline of June 11, 2025. The contract employs fixed-price pricing with economic price adjustment and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The device will be performed and delivered from the company's...
- The Defense Health Agency's Medical Supply Chain awarded a $20,977 fixed-price delivery order to Boston Scientific Corp for the Watchman FLX Pro LAAC (Left Atrial Appendage Closure) Device on July 29, 2025, with completion expected by August 5, 2025. The contract represents an open competition award with no set-aside designation, with performance taking place at Boston Scientific's facility in Marlborough, Massachusetts. The Watchman FLX Pro is a cardiac implant device used to reduce stroke risk...
- Boston Scientific Corporation was awarded a $20,002 delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide Watchman FLX devices. The fixed-price contract with economic price adjustment has a period of performance through October 2023 and no set-aside designation was used. As a leading medical device manufacturer, Boston Scientific will likely deliver its Watchman left atrial appendage closure technology to...
- Boston Scientific Corp has been awarded a delivery order valued at $148.8K for the WATCHMAN FLX product, funded by Veterans Integrated Service Network 23 (VISN 23), a component of the Department of Veterans Affairs. The contract is classified as Firm Fixed Price with no set-aside designation, indicating open competition. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts, with an ultimate completion date of November 7, 2025. The WATCHMAN FLX is a left...
- The Defense Logistics Agency Troop Support Medical awarded a $40,004 delivery order to Boston Scientific Corporation, doing business as Boston Scientific, for 4561911032 WATCHMAN FLX devices. The fixed price with economic price adjustment contract has a period of performance from August 23, 2023 through August 30, 2023 and will be performed in Marlborough, Massachusetts. As a leading provider of medical devices, Boston Scientific will supply its WATCHMAN FLX left atrial appendage closure devices...
- This is a $4,203 fixed-price with economic price adjustment delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, for the supply of a WATCHMAN FLX PRO LAAC DEVICE. The contract has an ultimate completion date of October 1, 2024. Boston Scientific is a leading manufacturer of medical devices that provides innovative solutions to federal agencies, including the Department of Veterans Affairs (VA) and Defense Health...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F00FPDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $23,416 for WATCHMAN FLX PRO left atrial appendage closure devices by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on January 9, 2026, with an ultimate completion date of January 16, 2026, is structured as a fixed-price contract with economic price adjustment provisions and will be performed in Marlborough, Massachusetts. This award represents a typical task order issued against Boston Scientific's broader blanket purchase agreement with the Defense Health Agency, which serves as an indefinite delivery vehicle for specialized medical device procurement across the defense and veterans healthcare enterprise. This delivery order supports the federal government's critical supply chain requirements for advanced cardiac medical devices utilized across military healthcare facilities and Veterans Affairs medical centers. The WATCHMAN FLX PRO is an innovative left atrial appendage closure system used in cardiovascular interventions to reduce stroke risk in eligible patients with atrial fibrillation. No small business set-aside was applied to this award, allowing Boston Scientific to compete on an unrestricted basis. As a leading supplier of specialized medical technologies to federal healthcare agencies, Boston Scientific has demonstrated sustained capability in delivering complex cardiac and interventional devices that support the Defense Health Agency's mission to maintain accessible, high-quality medical care for military beneficiaries and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 1/8/26 |